About usHistoryCulture
EHS SystemQuality System
APICDMO
Work PhilosophyRecruitment News
To be the Reliable Supplier in the Global Pharmaceutical Supply Chain
Home > Business >
API CDMO
Cas No.：897016-82-9
Status：Established(US DMF)
Tirbanibulin (KX2-391) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.
E-mail Product Inquiry
内容整理中，敬请期待。。。
Title：
Cas No.：
Name：
Telephone：
E-mail：
Message：
Submit
